Streamlining immune cell therapy manufacturing workflows with single-use cytokines

Live30 webinars are thirty-minute presentations designed to update you on the latest innovations, applications, and data in a fast yet interactive format.

Transitioning an immune cell therapy program from research to the clinic requires consistent and scalable cell manufacturing processes. Streamlining cell manufacturing workflows by eliminating manual touchpoints reduces variability and supports process scaling.

Cytokine delivery is one such opportunity for workflow improvement. Traditionally, cytokines are supplied in large volumes, which require manual aliquoting prior to storage and use. This step introduces a risk of error, threatens consistency, and impedes scale-up. Bio-Techne has addressed this challenge with new single-use vials with process-optimized concentrations of our GMP cytokines for streamlined immune cell manufacturing.

In this webinar, we examine the workflow difficulties posed by traditional cytokine delivery and the benefits of transitioning to a single-use cytokine method. We will also explore the need for scalable, aseptic closed-systems for immune cell manufacturing and Bio-Techne’s plans to solve that need with complete workflow solutions.

In this webinar, you will learn more about:

• How consistent and scalable manufacturing workflows impact immune cell therapy development
• New single-use cytokines with process-optimized concentrations
• Comparing workflows using traditional and single-use cytokine methods

Gabriella Perell

Global Strategic Senior Product Manager at Bio-Techne

Gabriella Perell is a Global Strategic Senior Product Manager for the proteins division, and previously managed the cell and gene therapy product lines focused on immune and stem cell therapy tools at Bio-Techne. Prior to this, Gabriella worked in process development at Amgen. Gabriella obtained her doctorate from the University of Minnesota investigating protein-protein interactions, and holds a bachelors in Chemistry from the University of St. Thomas.

Watch now

SPEAKERS

Gabriella Perell

Global Strategic Senior Product Manager at Bio-Techne

You might also like

The benefits of single-use systems for enhanced process security

Eoin Dolan

4 September

Watch

Trends in innovation for downstream process intensification, product yield, single-use closed systems, and gentle ATMP bioprocessing: a KOL panel discussing 2024 insights in gene therapy manufacturing

Rachel Legmann, Andrew Tustian

27 February

Watch

Revolutionizing upstream gene therapy manufacturing with nanofiber microcarriers

J Counsell, L Chirica, L Mellby

27 November

Watch

Optimizing for the future: streamlining the production of T cell-based immunotherapies

Paula Lam, Soong Poh Loong

30 October

Watch